[11C]Choline as a PET biomarker for assessment of prostate cancer tumor models
- 1 June 2004
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 12 (11) , 2887-2893
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Synthesis, biodistribution and micro-PET imaging of a potential cancer biomarker carbon-11 labeled MMP inhibitor (2R)-2-[[4-(6-fluorohex-1-ynyl)phenyl]sulfonylamino]-3-methylbutyric acid [11C]methyl esterNuclear Medicine and Biology, 2003
- Micro-PET imaging and small animal models of diseaseCurrent Opinion in Immunology, 2003
- Synthesis and preliminary biological evaluation of radiolabeled O6-benzylguanine derivatives, new potential PET imaging agents for the DNA repair protein O6-alkylguanine-DNA alkyltransferase in breast cancerNuclear Medicine and Biology, 2003
- Synthesis and preliminary biological evaluation of 6-O-[11C]-[(methoxymethyl)benzyl]guanines, new potential PET breast cancer imaging agents for the DNA repair protein AGTBioorganic & Medicinal Chemistry Letters, 2003
- Synthesis and preliminary biological evaluation of MMP inhibitor radiotracers [11C]methyl-halo-CGS 27023A analogs, new potential PET breast cancer imaging agentsNuclear Medicine and Biology, 2002
- Synthesis of MMP inhibitor radiotracers [11C]methyl‐CGS 27023A and its analogs, new potential PET breast cancer imaging agentsJournal of Labelled Compounds and Radiopharmaceuticals, 2002
- Molecular ImagingRadiology, 2001
- 18F-labeled radiopharmaceuticals for PET in oncology, excluding FDGNuclear Medicine and Biology, 2000
- Automated synthesis of [11C]choline, a positron-emitting tracer for tumor imagingApplied Radiation and Isotopes, 1999
- FDG uptake, tumour characteristics and response to therapyNuclear Medicine Communications, 1998